RT Journal Article
T1 Modeling cost-effectiveness analysis of treatment sequencing
A1 Del Campo Campos, Cristina
A1 Bai, Jiaru
A1 Keller, L. Robin
AB In clinical practice, patients with cancer often undergo treatment with a sequence of drugs, usually because of diminishing effectiveness over time or resistance development. However, few cost-effectiveness analyses have included that fact in their model. This paper aims at closing that gap by presenting a model that reflects the possibility of the patient switching from one therapeutic agent to another one throughout the long-term duration of his/her life.
PB Elsevier
SN 0038-0121
YR 2025
FD 2025-06-01
LK https://hdl.handle.net/20.500.14352/120473
UL https://hdl.handle.net/20.500.14352/120473
LA eng
NO del Campo, C., Bai, J., & Keller, L. R. (2025). Modeling cost-effectiveness analysis of treatment sequencing. Socio-Economic Planning Sciences, 99, 102210.
DS Docta Complutense
RD 4 oct 2025